Evaxion Biotech A/S
NASDAQ:EVAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Evaxion Biotech A/S
NASDAQ:EVAX
|
DK |
|
C
|
Compagnie Financiere Richemont SA
OTC:CFRHF
|
CH |
|
Conocophillips
NYSE:COP
|
US |
|
N
|
Nissan Motor Co Ltd
XBER:NISA
|
JP |
|
Intellect Design Arena Ltd
NSE:INTELLECT
|
IN |
|
B
|
Brembo SpA
MIL:BRE
|
IT |
|
S
|
Shell PLC
PSE:SHELL
|
UK |
|
A
|
Actic Group AB
F:8XA
|
SE |
|
Equitable Holdings Inc
F:AXJ
|
US |
|
Rushil Decor Ltd
NSE:RUSHIL
|
IN |
|
C
|
Cohen & Steers Inc
F:FG9
|
US |
|
6
|
60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
|
US |
|
LendLease Group
ASX:LLC
|
AU |
|
E
|
ESI Group SA
F:EGJ
|
FR |
|
T
|
Teleflex Inc
F:TBH
|
US |
Wall St Price Targets
EVAX Price Targets Summary
Evaxion Biotech A/S
According to Wall Street analysts, the average 1-year price target for
EVAX is 11.48 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EVAX's stock price target?
Price Target
11.48
USD
According to Wall Street analysts, the average 1-year price target for
EVAX is 11.48 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.
What is the Revenue forecast for Evaxion Biotech A/S?
Projected CAGR
62%
The compound annual growth rate for Revenue over the next 8 years is 62%.